➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
McKesson
Express Scripts
Boehringer Ingelheim
Johnson and Johnson

Last Updated: July 30, 2021

DrugPatentWatch Database Preview

PRIFTIN Drug Patent Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Priftin, and what generic alternatives are available?

Priftin is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in PRIFTIN is rifapentine. Two suppliers are listed for this compound. Additional details are available on the rifapentine profile page.

Drug patent expirations by year for PRIFTIN
Drug Prices for PRIFTIN

See drug prices for PRIFTIN

Recent Clinical Trials for PRIFTIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Chang Gung Memorial HospitalPhase 3
Kaohsiung Veterans General Hospital.Phase 3
National Taiwan UniversityPhase 3

See all PRIFTIN clinical trials

Pharmacology for PRIFTIN

US Patents and Regulatory Information for PRIFTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us PRIFTIN rifapentine TABLET;ORAL 021024-001 Jun 22, 1998 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
McKesson
Express Scripts
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.